Home > Insider Trading > Filing (0001628280-23-029148)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1501697	X4 Pharmaceuticals Inc	XFOR	Biological Products, (No Disgnostic Substances) (2836)	273181608

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1723450	Murray Stewart	C/O X4 Pharmaceuticals, Inc. 61 North Beacon Street, 4Th Floor Boston MA 02134	Interim Chief Medical Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-09	269,893	$0.00	276,560	No	4	A	Direct
Common Stock	Disposition	2023-08-10	130,056	$1.06	146,504	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Represents shares of common stock acquired upon acceleration of the vesting of a performance-based restricted stock unit grant.
Represents nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.02 to $1.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.